30 studies found for:    RGD
Show Display Options
Rank Status Study
1 Completed Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Tenckhoff Catheter placement;   Drug: Ad5-delta24RGD
2 Completed Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
Conditions: Metastatic Breast Cancer;   Metastatic Colon/Rectum Cancer;   Non-squamous Non-small Cell Lung Cancer
Intervention: Drug: [F-18]RGD-K5
3 Unknown  Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque
Conditions: Inflammation;   Atheromatous Plaques;   Carotid Artery Diseases
Intervention: Radiation: 68Ga-NODAGA-RGD PET/CT
4 Completed Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Conditions: Sarcoma;   Melanoma;   Lung Cancer;   Breast Cancer;   High Grade Gliomas
Intervention: Drug: F-18 RGD-K5
5 Terminated
Has Results
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
Condition: Carotid Stenosis
Intervention: Drug: [F-18]RDG-K5
6 Unknown  Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Recurring Glioblastoma
Intervention: Biological: delta-24-RGD adenovirus
7 Enrolling by invitation RGD-K5 in Head and Neck Cancer Patients
Condition: Head and Neck Neoplasms
Intervention:
8 Active, not recruiting DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Conditions: Brain Cancer;   Central Nervous System Diseases
Interventions: Drug: DNX-2401;   Procedure: Tumor Removal
9 Recruiting RGD-PET-CT in Cancer Angiogenesis
Condition: Carcinoma, Renal Cell
Intervention: Drug: 18F-RGD-PET-CT and perfusion CT scans on 3 occasions
10 Not yet recruiting TRACER RGD-K5 Carotid Plaque Imaging Study
Conditions: Carotid Artery Disease;   Carotid Stenosis
Intervention: Drug: [F-18] RDG-K5
11 Completed A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
Condition: Ovarian Cancer
Interventions: Genetic: Ad5.SSTR/TK.RGD;   Drug: Ganciclovir (GCV)
12 Recruiting 18F FPPRGD2 Positron Emission Tomography/Computed Tomography in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Radiation: fludeoxyglucose F 18;   Radiation: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
13 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide
14 Unknown  PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer
Condition: Breast Cancer
Intervention:
15 Recruiting A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Condition: Glioblastoma
Interventions: Other: Chemoradiation Therapy;   Other: Adjuvant Therapy
16 Unknown  Efferocytosis and Genomic Polymorphism in Autoimmune Diseases
Conditions: SLE;   Rheumatoid Arthritis;   Healthy Subjects
Intervention:
17 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: 68Ga-BNOTA-PRGD2
18 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients
Condition: Lung Cancer
Intervention: Drug: 68Ga-BNOTA-PRGD2
19 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
Condition: Glioma
Intervention: Drug: 68Ga-BNOTA-PRGD2
20 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction
Condition: Coronary Artery Disease
Intervention: Drug: 68Ga-BNOTA-PRGD2

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years